# EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer

> **NCT00004258** · PHASE1 · COMPLETED · sponsor: **Indiana University** · enrollment: 40 (estimated)

## Conditions studied

- Chronic Myeloproliferative Disorders
- Leukemia
- Lymphoma
- Multiple Myeloma and Plasma Cell Neoplasm
- Myelodysplastic Syndromes
- Precancerous/Nonmalignant Condition
- Small Intestine Cancer
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** cilengitide

## Key facts

- **NCT ID:** NCT00004258
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-12
- **Primary completion:** 2001-08
- **Final completion:** 2001-09
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2014-09-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004258

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004258, "EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00004258. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*